Mahdi Moqri

Mahdi Moqri

Auto-generated profile, based on publicly available information

Mahdi Moqri

Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MMMahdi Moqri
Mahdi Moqri
CHChiara Herzog
Chiara Herzog
JPJesse R. Poganik
Jesse R. Poganik
KYKejun Ying
Kejun Ying
JJJamie N. Justice
Jamie N. Justice
LFLuigi Ferrucci
Luigi Ferrucci

11 September 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
DHDaniel Hornburg
Daniel Hornburg
SWSi Wu
Si Wu
MMMahdi Moqri
Mahdi Moqri
XZXin Zhou
Xin Zhou
Kevin ContrepoisKevin Contrepois
Kevin Contrepois
MSMichael P Snyder
Michael P Snyder
Lipids can be of endogenous or exogenous origin and affect diverse biological functions, including cell membrane maintenance, energy management and cellular signalling. Here, we report >800 lipid species, many of which are associated with health-to-disease transitions in diabetes, ageing and inflammation, as well as cytokine–lipidome networks. We performed comprehensive longitudinal lipidomic profiling and analysed >1,500 plasma samples from 112 participants followed for up to 9 years (average 3.2 years) to define the distinct physiological roles of complex lipid subclasses, including large and small triacylglycerols, ester- and ether-linked phosphatidylethanolamines, lysophosphatidylcholines, lysophosphatidylethanolamines, cholesterol esters and ceramides. Our findings reveal dynamic changes in the plasma lipidome during respiratory viral infection, insulin resistance and ageing, suggesting that lipids may have roles in immune homoeostasis and inflammation regulation. Individuals with insulin resistance exhibit disturbed immune homoeostasis, altered associations between lipids and clinical markers, and accelerated changes in specific lipid subclasses during ageing. Our dataset based on longitudinal deep lipidome profiling offers insights into personalized ageing, metabolic health and inflammation, potentially guiding future monitoring and intervention strategies.

19 January 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
KYKejun Ying
Kejun Ying
HLHanna Liu
Hanna Liu
ATAndrei E. Tarkhov
Andrei E. Tarkhov
MSMarie C. Sadler
Marie C. Sadler
ALAke T. Lu
Ake T. Lu
VGVadim N Gladyshev
Vadim N Gladyshev

16 September 2024 in Nature Aging
Verified
Journal Article
Closed access
BCBiomarkers of Aging Consortium
Biomarkers of Aging Consortium
CHChiara M. S. Herzog
Chiara M. S. Herzog
LGLudger J. E. Goeminne
Ludger J. E. Goeminne
JPJesse R. Poganik
Jesse R. Poganik
NBNir Barzilai
Nir Barzilai
VGVadim N Gladyshev
Vadim N Gladyshev

28 November 2024 in PNAS Nexus
Verified
Journal Article
Open access
VGVadim N Gladyshev
Vadim N Gladyshev
BABenjamin Anderson
Benjamin Anderson
HBHanna Barlit
Hanna Barlit
BBBenjamin Barré
Benjamin Barré
SBSamuel Beck
Samuel Beck
AZAlex Zhavoronkov
Alex Zhavoronkov
To gain insight into how researchers of aging perceive the process they study, we conducted a survey among experts in the field. While highlighting some common features of aging, the survey exposed broad disagreement on the foundational issues. What is aging? What causes it? When does it begin? What constitutes rejuvenation? Not only was there no consensus on these and other core questions, but none of the questions received a majority opinion—even regarding the need for consensus itself. Despite many researchers believing they understand aging, their understanding diverges considerably. Importantly, as different processes are labeled as “aging” by researchers, different experimental approaches are prioritized. The survey shed light on the need to better define which aging processes this field should target and what its goals are. It also allowed us to categorize contemporary views on aging and rejuvenation, revealing critical, yet largely unanswered, questions that appear disconnected from the current research focus. Finally, we discuss ways to address the disagreement, which we hope will ultimately aid progress in the field.

16 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMahdi Moqri
Mahdi Moqri
ACAndrea Cipriano
Andrea Cipriano
DSDaniel J. Simpson
Daniel J. Simpson
SRSajede Rasouli
Sajede Rasouli
TMTara Murty
Tara Murty
VSVittorio Sebastiano
Vittorio Sebastiano
DNA methylation (DNAm) is one of the most reliable biomarkers of aging across mammalian tissues. While the age-dependent global loss of DNAm has been well characterized, DNAm gain is less characterized. Studies have demonstrated that CpGs which gain methylation with age are enriched in Polycomb Repressive Complex 2 (PRC2) targets. However, whole-genome examination of all PRC2 targets as well as determination of the pan-tissue or tissue-specific nature of these associations is lacking. Here, we show that low-methylated regions (LMRs) which are highly bound by PRC2 in embryonic stem cells (PRC2 LMRs) gain methylation with age in all examined somatic mitotic cells. We estimated that this epigenetic change represents around 90% of the age-dependent DNAm gain genome-wide. Therefore, we propose the “PRC2-AgeIndex,” defined as the average DNAm in PRC2 LMRs, as a universal biomarker of cellular aging in somatic cells which can distinguish the effect of different anti-aging interventions.